Back to today’s briefing

Story perspectives

J.P. Morgan Conference Sparks Biotech Optimism for 2025

1/8/2025

41 5

Summary

Story summary

The J.P. Morgan Healthcare Conference kicks off on January 13 in San Francisco, radiating hope for biotech and pharma in 2025. Early 2024 saw a remarkable 100% surge in mergers and acquisitions, fueled by interest rate cuts. Investors are keenly eyeing oncology, AI-driven drug discovery, and a potential pivot towards CNS and metabolic disorders in clinical trials.

1 of 1

Story summary

The J.P. Morgan Healthcare Conference kicks off on January 13 in San Francisco, radiating hope for biotech and pharma in 2025. Early 2024 saw a remarkable 100% surge in mergers and acquisitions, fueled by interest rate cuts. Investors are keenly eyeing oncology, AI-driven drug discovery, and a potential pivot towards CNS and metabolic disorders in clinical trials.